Colorectal Cancer Screening Has an Admin Problem That VAs Can Solve
Colorectal cancer (CRC) remains the second leading cause of cancer death in the United States, yet the American Cancer Society estimates that approximately 40% of eligible adults are not current on recommended CRC screening. A significant portion of that screening gap is not due to patient refusal or clinical failure—it is due to administrative breakdown: results that aren't routed, referrals that aren't made, surveillance intervals that aren't tracked, and follow-up calls that aren't placed.
GI oncology and CRC screening programs—whether based in academic medical centers, high-volume community GI practices, or health system population health departments—are increasingly deploying virtual assistants trained in cancer screening administration to close these gaps. The workflows involved (Lynch syndrome referral coordination, hereditary CRC surveillance scheduling, FIT and stool DNA result routing, CT colonography coordination) are repetitive, time-sensitive, and consequential—exactly the profile where well-trained VAs deliver measurable value.
Lynch Syndrome Genetic Counseling Referrals: Closing the Mismatch Repair Gap
Lynch syndrome—caused by germline mutations in mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2—is the most common hereditary CRC syndrome, accounting for approximately 3% of all CRC cases. Universal tumor MMR testing (by IHC or MSI-PCR) on newly diagnosed CRC specimens is now recommended by all major guidelines, and reflexive germline testing referral for MMR-deficient tumors is standard of care.
The administrative challenge is that a positive MMR-deficiency result triggers a cascade that must happen reliably: the pathology result must be flagged, the patient's gastroenterologist or oncologist notified, a genetic counseling referral generated, and the referral tracked to completion. A 2023 study in Genetics in Medicine found that only 52% of newly diagnosed CRC patients with MMR-deficient tumors completed genetic counseling referral within 90 days—a gap driven primarily by administrative follow-through failures.
VAs supporting GI oncology programs manage Lynch syndrome referral workflows: monitoring pathology queues for MMR-deficient results, generating pre-templated genetic counseling referral letters for provider e-signature, tracking referral completion in the EHR, scheduling genetic counseling appointments, and coordinating surveillance colonoscopy recommendations for confirmed Lynch patients and first-degree relatives. This closed-loop referral management closes the genetic counseling completion gap without requiring additional clinical staff.
FIT and Stool DNA Result Routing: The Last-Mile Problem in Non-Invasive Screening
Fecal immunochemical testing (FIT) and stool DNA testing (Cologuard, Exact Sciences) are the most widely used non-invasive CRC screening options in the U.S. When positive—which occurs in approximately 9% of FIT tests and 13% of Cologuard tests—patients require diagnostic colonoscopy follow-up. But the result routing and follow-up coordination workflow is frequently where the system breaks down.
A 2024 analysis in JAMA Internal Medicine found that among patients with a positive non-invasive CRC screening test, only 62% completed follow-up colonoscopy within six months—and primary care follow-up failure was the most commonly cited administrative reason. GI practices and screening programs that accept positive FIT/Cologuard referrals can deploy VAs to systematically close this gap: receiving positive result notifications from the lab or ordering provider, initiating colonoscopy scheduling outreach within 48 hours, documenting referral source and result value in the scheduling encounter, and tracking follow-up completion against the target 6-month window.
CT Colonography Coordination: Bridging Radiology and GI
CT colonography (CTC)—also called virtual colonoscopy—is an approved CRC screening modality for average-risk adults, particularly those with contraindications to optical colonoscopy or who prefer non-endoscopic screening. CTC requires bowel preparation, radiology scheduling, insurance precertification (coverage varies significantly by payer), and a structured workflow for managing positive findings that require follow-up colonoscopy.
VAs coordinating CTC workflows manage the full administrative chain: confirming insurance coverage for CTC in average-risk vs. high-risk patients (a critical distinction, as many payers only cover CTC for high-risk or contraindicated patients), scheduling radiology appointments with CTC-capable scanners, dispatching prep instructions, and routing radiology reports back to the ordering gastroenterologist. For CTC studies with polyps 6mm or larger—which require follow-up colonoscopy under current guidelines—VAs generate colonoscopy referral workflows and track completion.
The Population-Scale Case for GI Oncology VAs
CRC screening programs are increasingly measured on population-level completion rates, and health system value-based contracts are beginning to tie payment to screening adherence metrics. The administrative infrastructure required to close the screening gap at scale—tracking thousands of patients across multiple screening modalities, ensuring result routing, coordinating genetic referrals—is beyond what clinical staff alone can provide.
For GI oncology and CRC screening programs building out administrative infrastructure, Stealth Agents offers virtual assistants trained in cancer screening coordination, result routing, and hereditary GI surveillance workflows.
Sources
- American Cancer Society. Colorectal Cancer Facts & Figures 2023–2025. 2023.
- Bonadies DC, et al. "Lynch syndrome genetic counseling referral completion rates." Genetics in Medicine. 2023.
- Doubeni CA, et al. "Follow-up after positive non-invasive CRC screening." JAMA Internal Medicine. 2024.
- American College of Radiology. CT Colonography Reporting and Data System (C-RADS). 2023.